UHC2030 Co-Chairs’ statement on COVID-19 and UHC
The UHC2030 working group on Sustainability, Transition from Aid and Health Systems Strengthening held its first face-to-face meeting on 30-31 March 2016 in Geneva, Switzerland.
Why a ‘Transition’ working group?
All low- and middle-income countries face a number of critical pressures on their health systems. Some of these are particularly salient for countries that are currently or will soon be “transitioning” to much lower levels of external financial support.
A common guiding principle is to maintain or even increase effective coverage for priority health services, including those currently supported with external funds.
This does however not mean simply channelling government revenues to pay for a previously donor-funded program. Rather, transition provides an opportunity for countries to assess how governance, financing and service delivery are configured to ensure the sustainability of effective coverage for priority interventions.
Hence, health system strengthening (HSS) is at the core of the response to transition if progress towards UHC is to be sustained.
The focus of work for this new working group will be to build consensus around core issues and objectives in response to the transition from aid, develop guidance and principles for good practice and explore the types of reforms and investments needed to support an effective transition process. This initial consultative meeting will identify the specific actions that are going to be useful to take the work forward and support collective efforts in this area. More information will follow soon.
• Veronica Walford, UHC2030 consultant and Clare Dickinson, UHC2030 consultant
• Agnes Soucat: Director, Health Systems Governance and Finance, WHO
• Triin Habicht, Senior Adviser to the Ministry of Health, Estonia
• Aquina Thulare, Technical Specialist, Health Economics, National Health Insurance, South Africa
• Nellie Malefetse, Director of International Relations for Health, South Africa
• Pungkas Bahjuri Ali, Director of Community Health and Nutrition, Ministry of National Planning, Indonesia
• Regina Ombam, Deputy Director, HIV Investments, National Aids Council, Kenya
• Bruno Rivalan, Director, Action Santé Mondiale/Global Health Advocates
• Camilo Cid, Advisor, Health Economics & Financing, PAHO /WHO Regional Office for the Americas
• Nertila Tavanxhi, Technical Adviser, Evaluation & Economics, UNAIDS
• Joe Kutzin, Health Financing Coordinator, WHO
• Ajay Tandon, Lead Economist, World Bank
• Susan Sparkes, WHO, Health Financing Policy
• Gilles Forte, WHO, Essential Health Products and Medicines
• David Clarke WHO legal frameworks and procurement
• Objectives of IHP for UHC2030
• Scope of the STWG